China Resources Sanjiu Medical & Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
China Resources Sanjiu Medical & Pharmaceutical has a total shareholder equity of CN¥26.1B and total debt of CN¥2.6B, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are CN¥40.8B and CN¥14.7B respectively. China Resources Sanjiu Medical & Pharmaceutical's EBIT is CN¥4.1B making its interest coverage ratio -106.9. It has cash and short-term investments of CN¥8.8B.
Key information
10.0%
Debt to equity ratio
CN¥2.61b
Debt
| Interest coverage ratio | -106.9x |
| Cash | CN¥8.85b |
| Equity | CN¥26.06b |
| Total liabilities | CN¥14.71b |
| Total assets | CN¥40.77b |
Recent financial health updates
Recent updates
Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Trading At A 39% Discount?
Jan 03
Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Nov 18Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results
Aug 26Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?
Aug 09Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Jul 12China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50
Jun 09China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Apr 23An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued
Apr 16Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings
Mar 20Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?
Feb 28Financial Position Analysis
Short Term Liabilities: 000999's short term assets (CN¥23.1B) exceed its short term liabilities (CN¥12.3B).
Long Term Liabilities: 000999's short term assets (CN¥23.1B) exceed its long term liabilities (CN¥2.4B).
Debt to Equity History and Analysis
Debt Level: 000999 has more cash than its total debt.
Reducing Debt: 000999's debt to equity ratio has increased from 0.2% to 10% over the past 5 years.
Debt Coverage: 000999's debt is well covered by operating cash flow (166.7%).
Interest Coverage: 000999 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/22 17:09 |
| End of Day Share Price | 2025/01/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is covered by 39 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Changming He | BOCI Research Ltd. |
| Jessica Li | BofA Global Research |
| Shuchang Liu | Changjiang Securities Co. LTD. |